Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device
NCT: NCT06772142 · RECRUITING
Brief Summary
A multicenter, 30 patient prospective single arm evaluation of the Nervonik system in symptomatic patients with chronic severe knee, elbow or shoulder pain. COHORT 1: The initial cohort of patients will receive the Nervonik neurostimulator for up to 8 hours. The patient will remain local to the care facility for implant stimulator program changes until the patient is satisfied with the degree of pain relief. The implant will be removed from the patient at the end of the evaluation. COHORT 2: The second cohort of patients will include those patients from cohort 1 who have determined the Nervonik implant provides suitable pain relief and agree to have a permanent implant placed. In addition, the second cohort includes non-cohort one patients meeting the trial requirements and agreeing to participate in the trial.
Frequently Asked Questions
What is Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device?
Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device is a clinical trial registered under NCT06772142. Current status: RECRUITING.
What is the status of NCT06772142?
The current status of NCT06772142 (Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device) is: RECRUITING.
When did Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device start?
Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device started on 2024-11-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.